Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers

Shinichi Toyooka, Masaki Tokumo, Hisayuki Shigematsu, Keitaro Matsuo, Hiroaki Asano, Kunitoshi Tomii, Shuji Ichihara, Makoto Suzuki, Motoi Aoe, Hiroshi Date, Adi F. Gazdar, Nobuyoshi Shimizu

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

Genetic and epigenetic alterations are considered to play important roles in lung cancer. Recent studies showed that EGFR and K-RAS mutations exhibited a mutually exclusive pattern in adenocarcinoma of the lung, suggesting the presence of two independent oncogenic pathways. However, it is unknown how epigenetic alterations were involved in lung carcinogenesis mediated by EGFR or K-RAS mutation. In this study, we examined the relationship between genetic and epigenetic alterations in 164 cases of lung adenocarcinoma. Somatic mutations were determined by direct sequence of EGFR exons 18 to 21 and K-RAS codons 12 and 13. Methylation status of p16INK4a, RASSF1A, APC, RARβ, and CDH13, frequently methylated in lung cancer, was determined by methylation-specific PCR and the degree of methylation was defined as the methylation index. Multivariate analysis adjusted for age, sex, and smoking dose showed that the probability of having EGFR mutation was significantly lower among those with p16INK4a and CDH13 methylation than in those without [p16INK4a: odds ratio (OR), 0.07; 95% confidence interval (95% CI), 0.02-0.33; CDH13: OR, 0.34; 95% CI, 0.15-0.77] and the methylation index was significantly lower in EGFR mutant cases than in wild type (OR, 0.70; 95% CI, 0.52-0.95). By contrast, K-RAS mutation was significantly higher in p16 INK4a methylated cases than in unmethylated cases (OR, 4.93; 95% CI, 1.54-15.7) and the methylation index was higher in K-RAS mutant cases than in wild type with marginal significance (OR, 1.46; 95% CI, 0.95-2.25). Our results indicate the differences in the evolvement of epigenetic alterations between the EGFR- and K-RAS-mediated tumorigenesis and suggest the specific interaction of genetic and epigenetic changes in tumorigenesis of lung cancer.

Original languageEnglish
Pages (from-to)1371-1375
Number of pages5
JournalCancer Research
Volume66
Issue number3
DOIs
Publication statusPublished - Feb 1 2006

Fingerprint

Epigenomics
Methylation
Odds Ratio
Confidence Intervals
Mutation
Lung Neoplasms
Carcinogenesis
Adenocarcinoma of lung
Codon
Exons
Multivariate Analysis
Smoking
Polymerase Chain Reaction
Lung

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. / Toyooka, Shinichi; Tokumo, Masaki; Shigematsu, Hisayuki; Matsuo, Keitaro; Asano, Hiroaki; Tomii, Kunitoshi; Ichihara, Shuji; Suzuki, Makoto; Aoe, Motoi; Date, Hiroshi; Gazdar, Adi F.; Shimizu, Nobuyoshi.

In: Cancer Research, Vol. 66, No. 3, 01.02.2006, p. 1371-1375.

Research output: Contribution to journalArticle

Toyooka, S, Tokumo, M, Shigematsu, H, Matsuo, K, Asano, H, Tomii, K, Ichihara, S, Suzuki, M, Aoe, M, Date, H, Gazdar, AF & Shimizu, N 2006, 'Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers', Cancer Research, vol. 66, no. 3, pp. 1371-1375. https://doi.org/10.1158/0008-5472.CAN-05-2625
Toyooka, Shinichi ; Tokumo, Masaki ; Shigematsu, Hisayuki ; Matsuo, Keitaro ; Asano, Hiroaki ; Tomii, Kunitoshi ; Ichihara, Shuji ; Suzuki, Makoto ; Aoe, Motoi ; Date, Hiroshi ; Gazdar, Adi F. ; Shimizu, Nobuyoshi. / Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. In: Cancer Research. 2006 ; Vol. 66, No. 3. pp. 1371-1375.
@article{d7b49d351a964f66969884ca0aeb654a,
title = "Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers",
abstract = "Genetic and epigenetic alterations are considered to play important roles in lung cancer. Recent studies showed that EGFR and K-RAS mutations exhibited a mutually exclusive pattern in adenocarcinoma of the lung, suggesting the presence of two independent oncogenic pathways. However, it is unknown how epigenetic alterations were involved in lung carcinogenesis mediated by EGFR or K-RAS mutation. In this study, we examined the relationship between genetic and epigenetic alterations in 164 cases of lung adenocarcinoma. Somatic mutations were determined by direct sequence of EGFR exons 18 to 21 and K-RAS codons 12 and 13. Methylation status of p16INK4a, RASSF1A, APC, RARβ, and CDH13, frequently methylated in lung cancer, was determined by methylation-specific PCR and the degree of methylation was defined as the methylation index. Multivariate analysis adjusted for age, sex, and smoking dose showed that the probability of having EGFR mutation was significantly lower among those with p16INK4a and CDH13 methylation than in those without [p16INK4a: odds ratio (OR), 0.07; 95{\%} confidence interval (95{\%} CI), 0.02-0.33; CDH13: OR, 0.34; 95{\%} CI, 0.15-0.77] and the methylation index was significantly lower in EGFR mutant cases than in wild type (OR, 0.70; 95{\%} CI, 0.52-0.95). By contrast, K-RAS mutation was significantly higher in p16 INK4a methylated cases than in unmethylated cases (OR, 4.93; 95{\%} CI, 1.54-15.7) and the methylation index was higher in K-RAS mutant cases than in wild type with marginal significance (OR, 1.46; 95{\%} CI, 0.95-2.25). Our results indicate the differences in the evolvement of epigenetic alterations between the EGFR- and K-RAS-mediated tumorigenesis and suggest the specific interaction of genetic and epigenetic changes in tumorigenesis of lung cancer.",
author = "Shinichi Toyooka and Masaki Tokumo and Hisayuki Shigematsu and Keitaro Matsuo and Hiroaki Asano and Kunitoshi Tomii and Shuji Ichihara and Makoto Suzuki and Motoi Aoe and Hiroshi Date and Gazdar, {Adi F.} and Nobuyoshi Shimizu",
year = "2006",
month = "2",
day = "1",
doi = "10.1158/0008-5472.CAN-05-2625",
language = "English",
volume = "66",
pages = "1371--1375",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers

AU - Toyooka, Shinichi

AU - Tokumo, Masaki

AU - Shigematsu, Hisayuki

AU - Matsuo, Keitaro

AU - Asano, Hiroaki

AU - Tomii, Kunitoshi

AU - Ichihara, Shuji

AU - Suzuki, Makoto

AU - Aoe, Motoi

AU - Date, Hiroshi

AU - Gazdar, Adi F.

AU - Shimizu, Nobuyoshi

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Genetic and epigenetic alterations are considered to play important roles in lung cancer. Recent studies showed that EGFR and K-RAS mutations exhibited a mutually exclusive pattern in adenocarcinoma of the lung, suggesting the presence of two independent oncogenic pathways. However, it is unknown how epigenetic alterations were involved in lung carcinogenesis mediated by EGFR or K-RAS mutation. In this study, we examined the relationship between genetic and epigenetic alterations in 164 cases of lung adenocarcinoma. Somatic mutations were determined by direct sequence of EGFR exons 18 to 21 and K-RAS codons 12 and 13. Methylation status of p16INK4a, RASSF1A, APC, RARβ, and CDH13, frequently methylated in lung cancer, was determined by methylation-specific PCR and the degree of methylation was defined as the methylation index. Multivariate analysis adjusted for age, sex, and smoking dose showed that the probability of having EGFR mutation was significantly lower among those with p16INK4a and CDH13 methylation than in those without [p16INK4a: odds ratio (OR), 0.07; 95% confidence interval (95% CI), 0.02-0.33; CDH13: OR, 0.34; 95% CI, 0.15-0.77] and the methylation index was significantly lower in EGFR mutant cases than in wild type (OR, 0.70; 95% CI, 0.52-0.95). By contrast, K-RAS mutation was significantly higher in p16 INK4a methylated cases than in unmethylated cases (OR, 4.93; 95% CI, 1.54-15.7) and the methylation index was higher in K-RAS mutant cases than in wild type with marginal significance (OR, 1.46; 95% CI, 0.95-2.25). Our results indicate the differences in the evolvement of epigenetic alterations between the EGFR- and K-RAS-mediated tumorigenesis and suggest the specific interaction of genetic and epigenetic changes in tumorigenesis of lung cancer.

AB - Genetic and epigenetic alterations are considered to play important roles in lung cancer. Recent studies showed that EGFR and K-RAS mutations exhibited a mutually exclusive pattern in adenocarcinoma of the lung, suggesting the presence of two independent oncogenic pathways. However, it is unknown how epigenetic alterations were involved in lung carcinogenesis mediated by EGFR or K-RAS mutation. In this study, we examined the relationship between genetic and epigenetic alterations in 164 cases of lung adenocarcinoma. Somatic mutations were determined by direct sequence of EGFR exons 18 to 21 and K-RAS codons 12 and 13. Methylation status of p16INK4a, RASSF1A, APC, RARβ, and CDH13, frequently methylated in lung cancer, was determined by methylation-specific PCR and the degree of methylation was defined as the methylation index. Multivariate analysis adjusted for age, sex, and smoking dose showed that the probability of having EGFR mutation was significantly lower among those with p16INK4a and CDH13 methylation than in those without [p16INK4a: odds ratio (OR), 0.07; 95% confidence interval (95% CI), 0.02-0.33; CDH13: OR, 0.34; 95% CI, 0.15-0.77] and the methylation index was significantly lower in EGFR mutant cases than in wild type (OR, 0.70; 95% CI, 0.52-0.95). By contrast, K-RAS mutation was significantly higher in p16 INK4a methylated cases than in unmethylated cases (OR, 4.93; 95% CI, 1.54-15.7) and the methylation index was higher in K-RAS mutant cases than in wild type with marginal significance (OR, 1.46; 95% CI, 0.95-2.25). Our results indicate the differences in the evolvement of epigenetic alterations between the EGFR- and K-RAS-mediated tumorigenesis and suggest the specific interaction of genetic and epigenetic changes in tumorigenesis of lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=32944468706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32944468706&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-2625

DO - 10.1158/0008-5472.CAN-05-2625

M3 - Article

C2 - 16452191

AN - SCOPUS:32944468706

VL - 66

SP - 1371

EP - 1375

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 3

ER -